Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Human Serum Albumin Market Expected to Be in 2029?

The market size for human serum albumin has seen robust growth in recent years. The market is projected to increase from $5.39 billion in 2024 to $5.79 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. Factors such as growing healthcare requirements, broader uses of human serum albumin, an aging demographic, rising demand for blood plasma derivatives, and an increase in liver disorders and related diseases have contributed to the growth during the history term.

In the coming years, a significant expansion is forecasted for the human serum albumin market. It is anticipated to reach $7.63 billion by 2029, growing at a compound annual rate (CAGR) of 7.1%. This growth during the forecast period is due to factors including increased access to essential medicines, wider therapeutic usage, burgeoning hospital numbers, developing healthcare facilities and government-driven initiatives. Key trends foreseen during this period involve cell-free protein production, CRISPR-genome engineered strains, ongoing manufacturing methodologies, transdermal delivery mechanisms and advancements in lyophilization.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27310&type=smp

What Are The Contributors To Demand In The Human Serum Albumin Market?

With liver diseases becoming increasingly rampant, the human serum albumin market is expected to witness substantial growth. Diseases that impair liver function such as cirrhosis, hepatitis, fatty liver disease, and liver cancer are classified under liver diseases. The surge in liver diseases is a direct result of the growing incidence of obesity, which in turn leads to non-alcoholic fatty liver disease (NAFLD), characterized by fat deposition, inflammation, and possible liver failure due to excess abdominal fat. Human serum albumin contributes to combating liver disease by boosting blood volume, reducing fluid accumulation, ensuring kidney function, and enhancing outcomes in complications like ascites and hepatorenal syndrome. A report released in July 2023 by the Office for Health Improvement & Disparities, a UK government department, indicates an increase of 22.0% in hospital admissions with liver disease as the primary diagnosis in the fiscal year ending 2022, with cases going up from 67,458 in 2021 to 82,290 in 2022. Hence, the rising incidence of liver diseases is propelling the growth of the human serum albumin market.

What Segmentation Categories Are Included In The Human Serum Albumin Market Analysis?

The human serum albumin market covered in this report is segmented

1) By Type Of Preparation: Recombinant Human Serum Albumin, Plasma-Derived Human Serum Albumin

2) By Formulation Type: Injection Solutions, Lyophilized Powder

3) By Distribution Channel: Direct Sales, Online Pharmacies, Third-party Distributors, Hospital Pharmacies

4) By Application: Volume Expanders, Drug Delivery Systems, Nutrition Enhancement, Diagnostic Agents

5) By End-User: Hospitals, Research Laboratories, Pharmaceutical Companies, Blood Banks

Subsegments:

1) By Recombinant Human Serum Albumin: Yeast-Based Recombinant Human Serum Albumin, Bacterial-Based Recombinant Human Serum Albumin, Plant-Based Recombinant Human Serum Albumin, Mammalian Cell-Based Recombinant Human Serum Albumin, Insect Cell-Based Recombinant Human Serum Albumin

2) By Plasma-Derived Human Serum Albumin: 5% Human Serum Albumin Solution, 20% Human Serum Albumin Solution, 25% Human Serum Albumin Solution, Lyophilized Human Serum Albumin, Fatty Acid-Free Human Serum Albumin

What Upcoming Trends Are Expected To Impact The Human Serum Albumin Market Globally?

Leading organizations active in the human serum albumin market are concentrating on the development of novel solutions, including animal-free recombinant excipients, to advance product safety, scalability, and adherence to regulatory guidelines in biomanufacturing applications. The term animal-free recombinant excipient pertains to a biologically manipulated inactive substance produced utilizing recombinant DNA technology that does not contain any components derived from animals or humans, thereby guaranteeing high purity and safety in applications related to pharmaceutical and biomanufacturing. For example, in April 2025, InVitri Inc., a company based in the US that supplies animal-free, recombinant proteins, and excipients, introduced Optibumin 25, the premier recombinant 25% human serum albumin in closed-system biomanufacturing. This particular human serum albumin has been specifically created for closed-system biomanufacturing and is designed for downstream processing, formulation, and cryopreservation practices. It is now obtainable in 100 mL single-use packets. Its composition, defined chemically and free of animal origin, assures high purity, consistency, and minimizes the risk of contamination. It is ready for GMP, scalable for large-scale production, and provides a steady, sterile solution that effortlessly assimilates into applications like viral vector production, stem cell conservation, vaccine development, and regenerative medical practices.

Who Are The Top-Ranked Companies In The Human Serum Albumin Market Today?

Major companies operating in the human serum albumin market are Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Merck KGaA, CSL Behring (CSL), Baxter International Inc., Grifols S A, Sartorius AG, Octapharma AG, Kedrion Biopharma, Shanghai RAAS Blood Products Co Ltd., Biotest Aktiengesellschaft, LFB Group, Hualan Biological Engineering Inc., Taibang Biologic Group, Kamada Ltd., InVitria Inc., Reliance Life Sciences, Bio Products Laboratory, Mitsubishi Tanabe Pharma, and Sichuan Yuanda Shuyang Pharmaceutical Co Ltd.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/human-serum-albumin-global-market-report

How Is Human Serum Albumin Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the human serum albumin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human serum albumin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=27310&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.